ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 61 filers reported holding ACELRX PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,000 | -33.3% | 19,478 | -17.9% | 0.00% | – |
| Q2 2022 | $6,000 | 0.0% | 23,735 | +16.3% | 0.00% | – |
| Q1 2022 | $6,000 | -45.5% | 20,401 | +0.8% | 0.00% | – |
| Q4 2021 | $11,000 | -71.1% | 20,231 | -45.2% | 0.00% | – |
| Q3 2021 | $38,000 | -35.6% | 36,930 | -14.0% | 0.00% | – |
| Q2 2021 | $59,000 | -73.1% | 42,966 | -66.6% | 0.00% | – |
| Q1 2021 | $219,000 | -44.3% | 128,809 | -59.3% | 0.00% | – |
| Q4 2020 | $393,000 | +35.1% | 316,632 | +54.3% | 0.00% | – |
| Q3 2020 | $291,000 | +2.1% | 205,233 | -12.8% | 0.00% | – |
| Q2 2020 | $285,000 | +11.8% | 235,331 | +9.0% | 0.00% | – |
| Q1 2020 | $255,000 | -33.1% | 215,809 | +19.4% | 0.00% | – |
| Q4 2019 | $381,000 | -45.5% | 180,806 | -43.1% | 0.00% | – |
| Q3 2019 | $699,000 | +8.5% | 318,001 | +24.8% | 0.00% | – |
| Q2 2019 | $644,000 | -16.3% | 254,709 | +15.4% | 0.00% | – |
| Q1 2019 | $769,000 | +240.3% | 220,799 | +125.4% | 0.00% | – |
| Q4 2018 | $226,000 | +93.2% | 97,955 | +222.2% | 0.00% | – |
| Q3 2018 | $117,000 | +11.4% | 30,403 | -1.9% | 0.00% | – |
| Q2 2018 | $105,000 | +72.1% | 31,003 | +7.3% | 0.00% | – |
| Q1 2018 | $61,000 | -1.6% | 28,903 | -5.2% | 0.00% | – |
| Q4 2017 | $62,000 | +47.6% | 30,495 | +239.0% | 0.00% | – |
| Q3 2017 | $42,000 | -26.3% | 8,995 | -66.3% | 0.00% | – |
| Q2 2017 | $57,000 | -54.8% | 26,717 | -32.7% | 0.00% | – |
| Q1 2017 | $126,000 | +18.9% | 39,717 | -2.7% | 0.00% | – |
| Q4 2016 | $106,000 | -4.5% | 40,807 | +43.7% | 0.00% | – |
| Q3 2016 | $111,000 | +326.9% | 28,403 | +196.3% | 0.00% | – |
| Q2 2016 | $26,000 | -36.6% | 9,585 | -29.2% | 0.00% | – |
| Q1 2016 | $41,000 | -48.1% | 13,538 | -34.2% | 0.00% | – |
| Q4 2015 | $79,000 | +338.9% | 20,574 | +263.6% | 0.00% | – |
| Q3 2015 | $18,000 | -85.1% | 5,659 | -80.3% | 0.00% | – |
| Q2 2015 | $121,000 | +255.9% | 28,694 | +236.6% | 0.00% | – |
| Q1 2015 | $34,000 | +325.0% | 8,524 | +641.2% | 0.00% | – |
| Q4 2014 | $8,000 | -81.0% | 1,150 | -85.1% | 0.00% | – |
| Q3 2014 | $42,000 | -99.6% | 7,741 | -99.3% | 0.00% | -100.0% |
| Q2 2014 | $11,952,000 | -25.4% | 1,166,120 | -12.6% | 0.01% | -28.6% |
| Q1 2014 | $16,025,000 | +11.4% | 1,334,341 | +4.9% | 0.01% | +16.7% |
| Q4 2013 | $14,383,000 | +12.3% | 1,271,797 | +7.1% | 0.01% | 0.0% |
| Q3 2013 | $12,802,000 | – | 1,187,557 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 6,574,060 | $27,874,000 | 1.68% |
| SENZAR ASSET MANAGEMENT, LLC | 798,381 | $3,385,000 | 0.58% |
| Cormorant Asset Management, LP | 850,000 | $3,604,000 | 0.48% |
| Palo Alto Investors LP | 2,135,739 | $9,056,000 | 0.40% |
| Opus Point Partners Management, LLC | 99,959 | $424,000 | 0.34% |
| Granahan Investment Management | 1,582,237 | $6,709,000 | 0.19% |
| Joel Isaacson & Co., LLC | 70,660 | $300,000 | 0.08% |
| MARINER INVESTMENT GROUP LLC | 59,700 | $253,000 | 0.06% |
| MYCIO WEALTH PARTNERS, LLC | 75,000 | $318,000 | 0.06% |
| Cornerstone Capital, Inc. | 59,200 | $251,000 | 0.06% |